Remodulin Co-pay Assistance Program
The Remodulin Co-Pay Assistance Program, offered through United Therapeutics, allows most eligible patients who enroll to pay as little as a $5 co-pay for each prescription—up to $8000 savings per year.
How do my patients enroll in this program?
Patients are eligible for this program if they:
- Have commercial (also known as private) insurance and are taking the medication for an FDA-approved indication
- Are residents of the US or Puerto Rico
Patients utilizing Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the program will no longer be eligible.
The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program. Void where prohibited, taxed, or restricted by law.
Support through United Therapeutics ASSIST
ASSIST, the Access Solutions and Support Team, is a United Therapeutics resource committed to helping your patients access their prescribed Remodulin. Patients can also learn more about possible financial support options available to them.
Once your patients start Remodulin treatment, an ASSIST advisor will work with you, your patients, and the Specialty Pharmacy to help them understand their insurance coverage, answer questions, and discuss financial assistance options.